Synthesis and preclinical evaluation of BAY 94-9392: A novel PET tracer for tumor specific imaging

被引:0
|
作者
Schmitt-Willich, Heribert
Berndt, Mathias
Friebe, Matthias
Koglin, Norman
Mueller, Andre
Gekeler, Volker
Dinkelborg, Ludger M.
机构
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
234-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [1] BAY 94-9392: A novel F-18 labeled tumor specific probe for PET/CT imaging - Dosimetry
    Smolarz, Kamilla
    Krause, Bernd Joachim
    Graner, Frank-Philipp
    Wagner, Franziska
    Bacher-Stier, Claudia
    Sparks, Rick
    Ramsay, Susan
    Fels, Lueder
    Dinkelborg, Ludger
    Schwaiger, Markus
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [2] Studies of the 18F L-glutamate derivative BAY 94-9392 in cancer patients: A novel radiopharmaceutical for PET imaging
    Mittra, Erik
    Mosci, Camila
    Iagaru, Andrei
    Fels, Luder
    Bacher-Stier, Claudia
    Chin, Frederick
    Gambhir, Sanjiv
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [3] BAY 94-9392-A new derivative of L-glutamate for tumor specific PET imaging
    Koglin, Norman
    Mueller, Andre
    Friebe, Matthias
    Berndt, Mathias
    Schmitt-Willich, Heribert
    Gekeler, Volker
    Dinkelborg, Ludger M.
    CANCER RESEARCH, 2011, 71
  • [4] BAY 94-9392-A novel F-18 L-glutamate derivative for tumor-specific PET imaging
    Koglin, Norman
    Mueller, Andre
    Berndt, Mathias
    Schmitt-Willich, Heribert
    Gekeler, Volker
    Friebe, Matthias
    Dinkelborg, Ludger
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [5] First Experience with Bay 94-9392, a Novel F-18 L-glutamate Derivative, for PET/CT Imaging in Patients with Hepatocellular Cancer
    Baek, S.
    Lim, Y. S.
    Lee, H. C.
    Lee, Y.
    Kim, J. S.
    Koglin, N.
    Fels, L.
    Bacher-Stier, C.
    Moon, D. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S182 - S182
  • [6] Synthesis of BAY94-9392-A novel F-18 labeled amino acid for tumor imaging
    Berndt, Mathias
    Friebe, Matthias
    Schmitt-Willich, Heribert
    Koglin, Norman
    Mueller, Andre
    Gekeler, Volker
    Dinkelborg, Ludger M.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S505 - S505
  • [7] Tumor-specific PET Imaging Using BAY 94-9392-a Novel F-18 Labeled L-Glutamate Derivative
    Mueller, A.
    Koglin, N.
    Berndt, M.
    Schmitt-Willich, H.
    Rausch, A.
    Gekeler, V.
    Friebe, M.
    Dinkelborg, L. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S180 - S180
  • [8] Pilot clinical trials of FSPG (BAY 94-9392): An 18F-labeled glutamate derivative for PET imaging of system xCactivity in tumors
    Baek, Sora
    Mittra, Erik
    Cho, Chang -Min
    Gong, Gyungyub
    Oh, Seung Jun
    Mosci, Camila
    Kumar, Meena
    Chin, Frederick T.
    Fels, Lueder M.
    Stephens, Andrew W.
    Koglin, Norman
    Mueller, Andre
    Dinkelborg, Ludger M.
    Moon, Dae Hyuk
    Gambhir, Sanjiv S.
    CANCER RESEARCH, 2012, 72
  • [9] BAY94-9392-A novel F-18 labeled amino acid for tumor imaging
    Friebe, Matthias
    Koglin, Norman
    Mueller, Andre
    Berndt, Mathias
    Schmitt-Willich, Heribert
    Gekeler, Volker
    Dinkelborg, Ludger M.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S218 - S218
  • [10] Pilot clinical trials of FSPG (BAY 94-9392): An 18F-labeled glutamate derivative for PET imaging of system xC-activity in tumors
    Baek, Sora
    Mittra, Erik
    Choi, Chang-Min
    Gong, Gyungyub
    Oh, Seung Jun
    Mosci, Camila
    Kumar, Meena
    Chin, Frederick T.
    Fels, Lueder M.
    Stephens, Andrew W.
    Koglin, Norman
    Mueller, Andre
    Dinkelborg, Ludger M.
    Moon, Dae Hyuk
    Gambhir, Sanjiv S.
    CANCER RESEARCH, 2012, 72